Latest News about MRK
Recent news which mentions MRK
From Benzinga
From Motley Fool
How To Trade US CPI: The Top 5 Mega-Cap Gainers And Losers Following Last 3 Inflation Reports
May 09, 2023
From Benzinga
2 Top Healthcare Stocks Defying the Bear Market
May 07, 2023
From Motley Fool
7 Hot Growth Stocks Poised to Triple in 2023
May 05, 2023
Tags
LYTS
NASDAQ:APLT,NASDAQ:LYTS,NASDAQ:ONDS,NASDAQ:LIFE,NASDAQ:OLPX,NASDAQ:CUE,NYSE:NU,NYSE:MRK
NU
From InvestorPlace
What's Going On With Immix Biopharma Stock Today
May 03, 2023
From Benzinga
Insurers Can't Use War Argument: Court Rules in Favor of Merck in $1.4 Billion Cyberattack Coverage Case
May 03, 2023
Tickers
MRK
From Benzinga
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug
May 01, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 28, 2023
From Benzinga
Germany's Possible Export Ban On Semiconductor Chemicals To China: What It Means For The U.S
April 27, 2023
From Benzinga
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
April 27, 2023
From Benzinga
Merck’s first-quarter earnings beat estimates, even as COVID-19 treatment sales plummet
April 27, 2023
From MarketWatch
Why Merck Stock Is Trading Higher Today
April 27, 2023
From Benzinga
From Motley Fool
Merck Makes a Bold Move That Could Transform Its Business
April 27, 2023
From Motley Fool
Meta Platforms stock rallies on results, Mobileye Global stock sinks and other stocks on the move
April 27, 2023
From MarketWatch
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
April 27, 2023
From Benzinga
An undiscovered universe of stocks is trading at ‘near generational lows,’ asset manager says
April 27, 2023
From MarketWatch
The 7 Best Stocks From Schwab’s Dividend ETF
April 26, 2023
From InvestorPlace
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
From Motley Fool
From Motley Fool
3 Pharma Stocks That Could See a Surge in Demand in 2023
April 24, 2023
From InvestorPlace
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
From Benzinga
Why Prometheus Biosciences Stock Is Skyrocketing This Week
April 20, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.